KSC · 009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
₩6,240-₩70 (-1.11%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
Loading market information…
KOE · 039840.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
DIO Corporation’s quoted price sits in the lower half of its reported 52-week range, 49.59% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
DIO Corporation’s forward annual dividend is ₩75 per share, paid annual. The forward yield is 0.77% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
DIO Corporation’s next earnings report is currently expected on Nov 17, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow DIO Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in South Korea, DIO Corporation is a key player in the manufacturing and distribution of dental implants. Its extensive range of implant systems includes UFII internal (both submerged and non-submerged), FTN external, and protem mini systems. The company further provides UV active components, activators, and essential instrument kits. In addition to dental implants, DIO offers dental digital solutions, a variety of dental products, and cardiovascular medical devices. Its global reach extends to approximately 70 countries through its export activities. The firm, which was founded in 1988, was initially known as DSI Co., Ltd before rebranding as DIO Corporation in August 2008. It is headquartered in Busan, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 01:24 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| ₩37.8B-3.16% vs estimate |
| Q3 2024 | Nov 15, 2024 | -₩493-689.64% vs estimate | ₩31.35B+19.03% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩6,240-₩70 (-1.11%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
₩3,965-₩35 (-0.88%)
JW Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 16.0% below the high.
₩19,250-₩120 (-0.62%)
Samjin Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.68% below the high.
₩35,600+₩200 (+0.56%)
Chong Kun Dang Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
₩13,950-₩290 (-2.04%)
Interojo Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.61% below the high.
₩8,070-₩160 (-1.94%)
Hana Pharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
₩8,600-₩230 (-2.6%)
Jeil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 55.42% below the high.
₩6,960+₩50 (+0.72%)
Ilyang Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
